Nicholas Investments Partners »

Palvella Therapeutics Inc Ne shares owned by Nicholas Investments Partners

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Nicholas Investments Partners from 13F filings

Historical chart of Nicholas Investments Partners investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Nicholas Investments Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Nicholas Investments Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.4M 28k 124.65

More positions owned by Nicholas Investments Partners

Bwx Technologies (BWXT)
Insmed Com Par $.01 (INSM)
Kratos Defense & Sec Solutio Com New (KTOS)
Ge Vernova (GEV)
Revolution Medicines (RVMD)
Embraer Sponsored Ads (EMBJ)
Modine Manufacturing (MOD)
Bridgebio Pharma (BBIO)
NVIDIA Corporation (NVDA)
Sterling Construction Company (STRL)
Cameco Corporation (CCJ)
Lincoln Educational Services Corporation (LINC)
Exxon Mobil Corporation (XOM)
Century Aluminum Company (CENX)
Carpenter Technology Corporation (CRS)

View all positions for Nicholas Investments Partners

Top funds holding Palvella Therapeutics Inc Ne

Suvretta Capital Management
First Light Asset Management
BVF
Frazier Life Sciences Management
BlackRock
Jennison Associates
Vanguard Capital Management
State Street Corporation
Federated Investors
T. Rowe Price Associates
Frontier Capital Management
Woodline Partners
Alliancebernstein
Siren
Caption Management

View all funds holding Palvella Therapeutics Inc Ne